Lowell J Rosman, MD in Andover, MA - Neurological Surgery

Lowell J Rosman, MD is a Neurological Surgery physician based in Andover, Massachusetts. Lowell J Rosman is licensed to practice in Massachusetts (license number 34450) and his current practice location is 51 School St, Andover, Massachusetts. He can be reached at his office (for appointments etc.) via phone at (978) 470-0861.

NPI number for Lowell J Rosman is 1124143052 and his current mailing address is 51 School St, Andover, Massachusetts. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1124143052.

Contact Information

	Lowell J Rosman, MD
	51 School St, Andover, MA 01810-4037
	(978) 470-0861
	Not Available

Physician's Profile

Full Name	Lowell J Rosman
Gender	Male
Speciality	Neurological Surgery
Location	51 School St, Andover, Massachusetts
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1124143052
Provider Enumeration Date: 03/20/2007
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Lowell J Rosman such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1124143052	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207T00000X	Neurological Surgery	34450 (Massachusetts)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Lowell J Rosman is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Lowell J Rosman, MD 51 School St, Andover, MA 01810-4037 Ph: (978) 470-0861	Lowell J Rosman, MD 51 School St, Andover, MA 01810-4037 Ph: (978) 470-0861

News Archive

Researchers discover new class of drugs that inhibits a 'master switch' in mantle cell lymphoma

A new class of drugs that inhibits a "master switch" involved in the vast majority of cases of mantle cell lymphoma (MCL), a fatal subtype of non-Hodgkin's lymphoma, has been discovered by researchers at Mount Sinai.

Only few clinical trials are being conducted to test drugs in pediatric patients

Although children are more likely than adults to suffer from many diseases, few clinical trials are being conducted to test drugs in pediatric patients, according to a study to be presented Saturday, April 28, at the Pediatric Academic Societies (PAS) annual meeting in Boston.

New study shows that brain's ability to manage stress depends on brain protein

The brain's ability to effectively deal with stress or to lack that ability and be more susceptible to depression, depends on a single protein type in each person's brain, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published November 12 in the journal Nature.

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

With the help of immune system-stimulating molecules that mimic bacterial components, researchers have used a type of cancer vaccine to both delay and prevent breast tumors in mice.

Lowell J Rosman, MD - Neurological Surgery in Andover, MA